Indian for-profit super-speciality eyecare chain ASG has announced it has raised Rs 308 crore in a funding round led by global investment firm Foundation Holdings.
Ophthalmology operators look set to pay the price of a new EU regulation. The European Device Regulation comes into force in May next year, and medtech suppliers are likely to pass the additional costs this places onto them on.
HBI talks to Tim Clover, CEO of ophthalmology medtech supplier Rayner and former CEO of ophthalmology operator Optegra about his take on the market, challenges and opportunities in the future, and plans for the company going forward, including coming to market in the next two years - or sooner.
As HBI exclusively predicted last week, Bergman Healthcare Clinics has announced it intends to acquire Swedish, Norwegian and Danish refractive eye care clinic chain Memira.
HBI hears from two sources that Memira, the Swedish eye surgery group based in Sweden, Norway and Denmark, is about to be bought. We name the buyer and speculate as to multiple.
A robust DACH session at HBI 2019 reached broad agreement over the most - and least - favourable areas for investment in healthcare in the region, but struggled to agree on the likely implication of the key legislation about to be brought in.
How is Europe's largest private equity invested market faring in these uncertain times, as staff shortages and the continuing uncertainty of Brexit make forecasting the future difficult? In most cases, better than you might think! This was the general response from HBI 2019's learned panel of UK and Ireland experts - but as always there were exceptions that proved the rule.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
